世界のクローン病治療薬市場：市場規模・現状・予測

• 英文タイトル：Global Crohn’s Disease Therapeutics Market Size, Status and Forecast 2019-2025

• レポートコード：QYR9N7041 • 出版社/出版日：QYResearch / 2019年6月14日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（受注後２～3営業日） • 産業分類：医療・製薬・バイオ

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Enterprise License	￥1,154,400 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当資料は、クローン病治療薬のグローバル市場について調査・分析したレポートで、種類別（非外科的、外科的）、用途別（病院、外来手術センター）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。 ・クローン病治療薬の世界市場規模 ・主要企業別市場シェア ・クローン病治療薬の世界市場規模：種類別（非外科的、外科的） ・クローン病治療薬の世界市場規模：用途別（病院、外来手術センター） ・クローン病治療薬のアメリカ市場規模（種類別、用途別） ・クローン病治療薬のヨーロッパ市場規模（種類別、用途別） ・クローン病治療薬の中国市場規模（種類別、用途別） ・クローン病治療薬の日本市場規模（種類別、用途別） ・クローン病治療薬の東南アジア市場規模（種類別、用途別） ・クローン病治療薬のインド市場規模（種類別、用途別） ・クローン病治療薬の中南米市場規模（種類別、用途別） ・主要企業別分析（企業概要、製品動向、販売量など） ・クローン病治療薬の世界市場予測（2019年-2025年） ・クローン病治療薬の地域別市場予測（2019年-2025年） ...

Prevalence of Crohn’s disease has increased in developing countries owing to industrialization, environmental factors such as differences in exposure to sunlight, changes in diet, smoking, and genetic characteristics. According to the Centers for Disease Control and Prevention (CDC), over 1 million Americans suffer from inflammatory bowel disease every year.Growing prevalence of the disease, along with increase in number of pipeline drugs, is expected to be a key factor driving the market.
In 2018, the global Crohn’s Disease Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Crohn’s Disease Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Crohn’s Disease Therapeutics development in United States, Europe and China.

The key players covered in this study
Johnson & Johnson Services Inc.
Pfizer Inc.
Allergan
AbbVie Inc.
Takeda Pharmaceutical Company Limited
Celgene Corporation
Perrigo Company PLC
Ferring B.V.
Salix Pharmaceuticals
Gilead Sciences Inc.
Genentech Inc.
UCB India Private Limited.

Market segment by Type, the product can be split into
Non-Surgical
Surgical

Market segment by Application, split into
Hospitals
Ambulatory Surgical Centers

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Crohn’s Disease Therapeutics status, future forecast, growth opportunity, key market and key players.
To present the Crohn’s Disease Therapeutics development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Crohn’s Disease Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

---

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Crohn’s Disease Therapeutics Market Size Growth Rate by Type (2014-2025)
1.4.2 Non-Surgical
1.4.3 Surgical
1.5 Market by Application
1.5.1 Global Crohn’s Disease Therapeutics Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Ambulatory Surgical Centers
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Crohn’s Disease Therapeutics Market Size
2.2 Crohn’s Disease Therapeutics Growth Trends by Regions
2.2.1 Crohn’s Disease Therapeutics Market Size by Regions (2014-2025)
2.2.2 Crohn’s Disease Therapeutics Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Crohn’s Disease Therapeutics Market Size by Manufacturers
3.1.1 Global Crohn’s Disease Therapeutics Revenue by Manufacturers (2014-2019)
3.1.2 Global Crohn’s Disease Therapeutics Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Crohn’s Disease Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2 Crohn’s Disease Therapeutics Key Players Head office and Area Served
3.3 Key Players Crohn’s Disease Therapeutics Product/Solution/Service
3.4 Date of Enter into Crohn’s Disease Therapeutics Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Crohn’s Disease Therapeutics Market Size by Type (2014-2019)
4.2 Global Crohn’s Disease Therapeutics Market Size by Application (2014-2019)

5 United States
5.1 United States Crohn’s Disease Therapeutics Market Size (2014-2019)
5.2 Crohn’s Disease Therapeutics Key Players in United States
5.3 United States Crohn’s Disease Therapeutics Market Size by Type
5.4 United States Crohn’s Disease Therapeutics Market Size by Application

6 Europe
6.1 Europe Crohn’s Disease Therapeutics Market Size (2014-2019)
6.2 Crohn’s Disease Therapeutics Key Players in Europe
6.3 Europe Crohn’s Disease Therapeutics Market Size by Type
6.4 Europe Crohn’s Disease Therapeutics Market Size by Application

7 China
7.1 China Crohn’s Disease Therapeutics Market Size (2014-2019)
7.2 Crohn’s Disease Therapeutics Key Players in China
7.3 China Crohn’s Disease Therapeutics Market Size by Type
7.4 China Crohn’s Disease Therapeutics Market Size by Application

8 Japan
8.1 Japan Crohn’s Disease Therapeutics Market Size (2014-2019)
8.2 Crohn’s Disease Therapeutics Key Players in Japan
8.3 Japan Crohn’s Disease Therapeutics Market Size by Type
8.4 Japan Crohn’s Disease Therapeutics Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Crohn’s Disease Therapeutics Market Size (2014-2019)
9.2 Crohn’s Disease Therapeutics Key Players in Southeast Asia
9.3 Southeast Asia Crohn’s Disease Therapeutics Market Size by Type
9.4 Southeast Asia Crohn’s Disease Therapeutics Market Size by Application

10 India
10.1 India Crohn’s Disease Therapeutics Market Size (2014-2019)
10.2 Crohn’s Disease Therapeutics Key Players in India
10.3 India Crohn’s Disease Therapeutics Market Size by Type
10.4 India Crohn’s Disease Therapeutics Market Size by Application

11 Central & South America
11.1 Central & South America Crohn’s Disease Therapeutics Market Size (2014-2019)
11.2 Crohn’s Disease Therapeutics Key Players in Central & South America
11.3 Central & South America Crohn’s Disease Therapeutics Market Size by Type
11.4 Central & South America Crohn’s Disease Therapeutics Market Size by Application

12 International Players Profiles
12.1 Johnson & Johnson Services Inc.
12.1.1 Johnson & Johnson Services Inc. Company Details
12.1.2 Company Description and Business Overview
12.1.3 Crohn’s Disease Therapeutics Introduction
12.1.4 Johnson & Johnson Services Inc. Revenue in Crohn’s Disease Therapeutics Business (2014-2019)
12.1.5 Johnson & Johnson Services Inc. Recent Development
12.2 Pfizer Inc.
12.2.1 Pfizer Inc. Company Details
12.2.2 Company Description and Business Overview
12.2.3 Crohn’s Disease Therapeutics Introduction
12.2.4 Pfizer Inc. Revenue in Crohn’s Disease Therapeutics Business (2014-2019)
12.2.5 Pfizer Inc. Recent Development
12.3 Allergan
12.3.1 Allergan Company Details
12.3.2 Company Description and Business Overview
12.3.3 Crohn’s Disease Therapeutics Introduction
12.3.4 Allergan Revenue in Crohn’s Disease Therapeutics Business (2014-2019)
12.3.5 Allergan Recent Development
12.4 AbbVie Inc.
12.4.1 AbbVie Inc. Company Details
12.4.2 Company Description and Business Overview
12.4.3 Crohn’s Disease Therapeutics Introduction
12.4.4 AbbVie Inc. Revenue in Crohn’s Disease Therapeutics Business (2014-2019)
12.4.5 AbbVie Inc. Recent Development
12.5 Takeda Pharmaceutical Company Limited
12.5.1 Takeda Pharmaceutical Company Limited Company Details
12.5.2 Company Description and Business Overview
12.5.3 Crohn’s Disease Therapeutics Introduction
12.5.4 Takeda Pharmaceutical Company Limited Revenue in Crohn’s Disease Therapeutics Business (2014-2019)
12.5.5 Takeda Pharmaceutical Company Limited Recent Development
12.6 Celgene Corporation
12.6.1 Celgene Corporation Company Details
12.6.2 Company Description and Business Overview
12.6.3 Crohn’s Disease Therapeutics Introduction
12.6.4 Celgene Corporation Revenue in Crohn’s Disease Therapeutics Business (2014-2019)
12.6.5 Celgene Corporation Recent Development
12.7 Perrigo Company PLC
12.7.1 Perrigo Company PLC Company Details
12.7.2 Company Description and Business Overview
12.7.3 Crohn’s Disease Therapeutics Introduction
12.7.4 Perrigo Company PLC Revenue in Crohn’s Disease Therapeutics Business (2014-2019)
12.7.5 Perrigo Company PLC Recent Development
12.8 Ferring B.V.
12.8.1 Ferring B.V. Company Details
12.8.2 Company Description and Business Overview
12.8.3 Crohn’s Disease Therapeutics Introduction
12.8.4 Ferring B.V. Revenue in Crohn’s Disease Therapeutics Business (2014-2019)
12.8.5 Ferring B.V. Recent Development
12.9 Salix Pharmaceuticals
12.9.1 Salix Pharmaceuticals Company Details
12.9.2 Company Description and Business Overview
12.9.3 Crohn’s Disease Therapeutics Introduction
12.9.4 Salix Pharmaceuticals Revenue in Crohn’s Disease Therapeutics Business (2014-2019)
12.9.5 Salix Pharmaceuticals Recent Development
12.10 Gilead Sciences Inc.
12.10.1 Gilead Sciences Inc. Company Details
12.10.2 Company Description and Business Overview
12.10.3 Crohn’s Disease Therapeutics Introduction
12.10.4 Gilead Sciences Inc. Revenue in Crohn’s Disease Therapeutics Business (2014-2019)
12.10.5 Gilead Sciences Inc. Recent Development
12.11 Genentech Inc.
12.12 UCB India Private Limited.

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Crohn’s Disease Therapeutics Key Market Segments
Table Key Players Crohn’s Disease Therapeutics Covered
Table Global Crohn’s Disease Therapeutics Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Crohn’s Disease Therapeutics Market Size Market Share by Type 2014-2025
Figure Non-Surgical Figures
Table Key Players of Non-Surgical
Figure Surgical Figures
Table Key Players of Surgical
Table Global Crohn’s Disease Therapeutics Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals Case Studies
Figure Ambulatory Surgical Centers Case Studies
Figure Crohn’s Disease Therapeutics Report Years Considered
Table Global Crohn’s Disease Therapeutics Market Size 2014-2025 (Million US$)
Figure Global Crohn’s Disease Therapeutics Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Crohn’s Disease Therapeutics Market Size by Regions 2014-2025 (Million US$)
Table Global Crohn’s Disease Therapeutics Market Size by Regions 2014-2019 (Million US$)
Table Global Crohn’s Disease Therapeutics Market Share by Regions 2014-2019
Figure Global Crohn’s Disease Therapeutics Market Share by Regions 2014-2019
Figure Global Crohn’s Disease Therapeutics Market Share by Regions 2019
Table Market Top Trends
Table Global Crohn’s Disease Therapeutics Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Crohn’s Disease Therapeutics Market Share by Manufacturers (2014-2019)
Figure Global Crohn’s Disease Therapeutics Market Share by Manufacturers in 2018
Table Global Crohn’s Disease Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Crohn’s Disease Therapeutics Product/Solution/Service
Table Date of Enter into Crohn’s Disease Therapeutics Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Crohn’s Disease Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Global Crohn’s Disease Therapeutics Market Size Share by Type (2014-2019)
Figure Global Crohn’s Disease Therapeutics Market Size Market Share by Type (2014-2019)
Table Global Crohn’s Disease Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Global Crohn’s Disease Therapeutics Market Size Share by Application (2014-2019)
Figure Global Crohn’s Disease Therapeutics Market Size Market Share by Application (2014-2019)
Figure Global Crohn’s Disease Therapeutics Revenue Market Share by Application in 2018
Figure United States Crohn’s Disease Therapeutics Market Size 2014-2019 (Million US$)
Table United States Key Players Crohn’s Disease Therapeutics Revenue (2018-2019) (Million US$)
Table United States Key Players Crohn’s Disease Therapeutics Market Share (2018-2019)
Table United States Crohn’s Disease Therapeutics Market Size by Type (2014-2019) (Million US$)
Table United States Crohn’s Disease Therapeutics Market Share by Type (2014-2019)
Table United States Crohn’s Disease Therapeutics Market Size by Application (2014-2019) (Million US$)
Table United States Crohn’s Disease Therapeutics Market Share by Application (2014-2019)
Figure Europe Crohn’s Disease Therapeutics Market Size 2014-2019 (Million US$)
Table Europe Key Players Crohn’s Disease Therapeutics Revenue (2018-2019) (Million US$)
Table Europe Key Players Crohn’s Disease Therapeutics Market Share (2018-2019)
Table Europe Crohn’s Disease Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Europe Crohn’s Disease Therapeutics Market Share by Type (2014-2019)
Table Europe Crohn’s Disease Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Europe Crohn’s Disease Therapeutics Market Share by Application (2014-2019)
Figure China Crohn’s Disease Therapeutics Market Size 2014-2019 (Million US$)
Table China Key Players Crohn’s Disease Therapeutics Revenue (2018-2019) (Million US$)
Table China Key Players Crohn’s Disease Therapeutics Market Share (2018-2019)
Table China Crohn’s Disease Therapeutics Market Size by Type (2014-20189) (Million US$)
Table China Crohn’s Disease Therapeutics Market Share by Type (2014-2019)
Table China Crohn’s Disease Therapeutics Market Size by Application (2014-2019) (Million US$)
Table China Crohn’s Disease Therapeutics Market Share by Application (2014-2019)
Figure Japan Crohn’s Disease Therapeutics Market Size 2014-2019 (Million US$)
Table Japan Key Players Crohn’s Disease Therapeutics Revenue (2018-2019) (Million US$)
Table Japan Key Players Crohn’s Disease Therapeutics Market Share (2018-2019)
Table Japan Crohn’s Disease Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Japan Crohn’s Disease Therapeutics Market Share by Type (2014-2019)
Table Japan Crohn’s Disease Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Japan Crohn’s Disease Therapeutics Market Share by Application (2014-2019)
Figure Southeast Asia Crohn’s Disease Therapeutics Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Crohn’s Disease Therapeutics Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Crohn’s Disease Therapeutics Market Share (2018-2019)
Table Southeast Asia Crohn’s Disease Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Crohn’s Disease Therapeutics Market Share by Type (2014-2019)
Table Southeast Asia Crohn’s Disease Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Crohn’s Disease Therapeutics Market Share by Application (2014-2019)
Figure India Crohn’s Disease Therapeutics Market Size 2014-2019 (Million US$)
Table India Key Players Crohn’s Disease Therapeutics Revenue (2018-2019) (Million US$)
Table India Key Players Crohn’s Disease Therapeutics Market Share (2018-2019)
Table India Crohn’s Disease Therapeutics Market Size by Type (2014-2019) (Million US$)
Table India Crohn’s Disease Therapeutics Market Share by Type (2014-2019)
Table India Crohn’s Disease Therapeutics Market Size by Application (2014-2019) (Million US$)
Table India Crohn’s Disease Therapeutics Market Share by Application (2014-2019)
Figure Central & South America Crohn’s Disease Therapeutics Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Crohn’s Disease Therapeutics Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Crohn’s Disease Therapeutics Market Share (2018-2019)
Table Central & South America Crohn’s Disease Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Central & South America Crohn’s Disease Therapeutics Market Share by Type (2014-2019)
Table Central & South America Crohn’s Disease Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Central & South America Crohn’s Disease Therapeutics Market Share by Application (2014-2019)
Table Johnson & Johnson Services Inc. Company Details
Table Johnson & Johnson Services Inc. Revenue in Crohn’s Disease Therapeutics Business (2014-2019) (Million US$)
Figure Johnson & Johnson Services Inc. Revenue Growth Rate in Crohn’s Disease Therapeutics Business (2014-2019)
Table Johnson & Johnson Services Inc. Recent Development
Table Pfizer Inc. Company Details
Table Pfizer Inc. Revenue in Crohn’s Disease Therapeutics Business (2014-2019)(Million US$)
Figure Pfizer Inc. Revenue Growth Rate in Crohn’s Disease Therapeutics Business (2014-2019)
Table Pfizer Inc. Recent Development
Table Allergan Company Details
Table Allergan Revenue in Crohn’s Disease Therapeutics Business (2014-2019)(Million US$)
Figure Allergan Revenue Growth Rate in Crohn’s Disease Therapeutics Business (2014-2019)
Table Allergan Recent Development
Table AbbVie Inc. Company Details
Table AbbVie Inc. Revenue in Crohn’s Disease Therapeutics Business (2014-2019)(Million US$)
Figure AbbVie Inc. Revenue Growth Rate in Crohn’s Disease Therapeutics Business (2014-2019)
Table AbbVie Inc. Recent Development
Table Takeda Pharmaceutical Company Limited Company Details
Table Takeda Pharmaceutical Company Limited Revenue in Crohn’s Disease Therapeutics Business (2014-2019)(Million US$)
Figure Takeda Pharmaceutical Company Limited Revenue Growth Rate in Crohn’s Disease Therapeutics Business (2014-2019)
Table Takeda Pharmaceutical Company Limited Recent Development
Table Celgene Corporation Company Details
Table Celgene Corporation Revenue in Crohn’s Disease Therapeutics Business (2014-2019)(Million US$)
Figure Celgene Corporation Revenue Growth Rate in Crohn’s Disease Therapeutics Business (2014-2019)
Table Celgene Corporation Recent Development
Table Perrigo Company PLC Company Details
Table Perrigo Company PLC Revenue in Crohn’s Disease Therapeutics Business (2014-2019)(Million US$)
Figure Perrigo Company PLC Revenue Growth Rate in Crohn’s Disease Therapeutics Business (2014-2019)
Table Perrigo Company PLC Recent Development
Table Ferring B.V. Company Details
Table Ferring B.V. Revenue in Crohn’s Disease Therapeutics Business (2014-2019)(Million US$)
Figure Ferring B.V. Revenue Growth Rate in Crohn’s Disease Therapeutics Business (2014-2019)
Table Ferring B.V. Recent Development
Table Salix Pharmaceuticals Company Details
Table Salix Pharmaceuticals Revenue in Crohn’s Disease Therapeutics Business (2014-2019)(Million US$)
Figure Salix Pharmaceuticals Revenue Growth Rate in Crohn’s Disease Therapeutics Business (2014-2019)
Table Salix Pharmaceuticals Recent Development
Table Gilead Sciences Inc. Company Details
Table Gilead Sciences Inc. Revenue in Crohn’s Disease Therapeutics Business (2014-2019)(Million US$)
Figure Gilead Sciences Inc. Revenue Growth Rate in Crohn’s Disease Therapeutics Business (2014-2019)
Table Gilead Sciences Inc. Recent Development
Table Genentech Inc. Company Details
Table UCB India Private Limited. Company Details
Table Global Crohn’s Disease Therapeutics Market Size by Regions (Million US$) 2019-2025
Figure Global Crohn’s Disease Therapeutics Market Size Share by Regions (2019-2025)
Figure Global Crohn’s Disease Therapeutics Market Size Share by Regions in 2025
Figure United States Crohn’s Disease Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Europe Crohn’s Disease Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure China Crohn’s Disease Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Japan Crohn’s Disease Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Crohn’s Disease Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure India Crohn’s Disease Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Crohn’s Disease Therapeutics Market Size Forecast (2019-2025)(Million USD)
Table Global Crohn’s Disease Therapeutics Market Size by Product (2019-2025) (Million US$)
Figure Global Crohn’s Disease Therapeutics Market Size by Product (2019-2025)
Figure Global Crohn’s Disease Therapeutics Market Size by Product in 2025
Table Global Crohn’s Disease Therapeutics Market Size by Application (2019-2025) (Million US$)
Figure Global Crohn’s Disease Therapeutics Market Size by Application (2019-2025)
Figure Global Crohn’s Disease Therapeutics Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

---